These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19569226)

  • 1. Crystallization of a polymorphic hydrate system.
    Tian F; Qu H; Louhi-Kultanen M; Rantanen J
    J Pharm Sci; 2010 Feb; 99(2):753-63. PubMed ID: 19569226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode.
    Nguyen TN; Kim KJ
    Int J Pharm; 2008 Nov; 364(1):1-8. PubMed ID: 18582549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal morphology modification by the addition of tailor-made stereocontrolled poly(N-isopropyl acrylamide).
    Munk T; Baldursdottir S; Hietala S; Rades T; Kapp S; Nuopponen M; Kalliomäki K; Tenhu H; Rantanen J
    Mol Pharm; 2012 Jul; 9(7):1932-41. PubMed ID: 22591051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-throughput hydrate screening using the Crystal 16™.
    Sistla A; Wu Y; Khamphavong P; Liu J
    Pharm Dev Technol; 2011 Apr; 16(2):102-9. PubMed ID: 20088649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of temperature on solvent-mediated anhydrate-to-hydrate transformation kinetics.
    Qu H; Munk T; Cornett C; Wu JX; Bøtker JP; Christensen LP; Rantanen J; Tian F
    Pharm Res; 2011 Feb; 28(2):364-73. PubMed ID: 20886266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitaxial 2D nucleation of the stable polymorphic form of the steroid 7alphaMNa on the metastable form: implications for Ostwald's rule of stages.
    Stoica C; Verwer P; Meekes H; Vlieg E; van Hoof PJ; Kaspersen FM
    Int J Pharm; 2006 Feb; 309(1-2):16-24. PubMed ID: 16384675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and selective crystallization of famotidine polymorphs.
    Lu J; Wang XJ; Yang X; Ching CB
    J Pharm Sci; 2007 Sep; 96(9):2457-68. PubMed ID: 17518361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of hydrate transition temperature using transformation kinetics obtained by Raman spectroscopy.
    Wikström H; Kakidas C; Taylor LS
    J Pharm Biomed Anal; 2009 Feb; 49(2):247-52. PubMed ID: 19112003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conversion process of hydrocarbon hydrates into CO2 hydrates and vice versa: thermodynamic considerations.
    Schicks JM; Luzi M; Beeskow-Strauch B
    J Phys Chem A; 2011 Nov; 115(46):13324-31. PubMed ID: 21928801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility and stability of anhydrate/hydrate in solvent mixtures.
    Qu H; Louhi-Kultanen M; Kallas J
    Int J Pharm; 2006 Sep; 321(1-2):101-7. PubMed ID: 16784825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polymer additives on the crystallization of hydrates: a molecular-level modulation.
    Tian F; Baldursdottir S; Rantanen J
    Mol Pharm; 2009; 6(1):202-10. PubMed ID: 19099494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvent influences on metastable polymorph lifetimes: real-time interconversions using energy dispersive X-ray diffractometry.
    DeMatos LL; Williams AC; Booth SW; Petts CR; Taylor DJ; Blagden N
    J Pharm Sci; 2007 May; 96(5):1069-78. PubMed ID: 17455330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique mechanism of facile polymorphic conversion of acetaminophen in aqueous medium.
    Gao Y; Olsen KW
    Mol Pharm; 2014 Sep; 11(9):3056-67. PubMed ID: 25111742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Batch cooling crystallization and pressure filtration of sulphathiazole: the influence of solvent composition.
    Häkkinen A; Pöllänen K; Karjalainen M; Rantanen J; Louhi-Kultanen M; Nyström L
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):17-28. PubMed ID: 15283678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hydrate-screening methods.
    Cui Y; Yao E
    J Pharm Sci; 2008 Jul; 97(7):2730-44. PubMed ID: 17914731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raman spectroscopic investigations on natural samples from the Integrated Ocean Drilling Program (IODP) Expedition 311: indications for heterogeneous compositions in hydrate crystals.
    Schicks JM; Ziemann MA; Lu H; Ripmeester JA
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Dec; 77(5):973-7. PubMed ID: 20863745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical stability of crystal hydrates and their anhydrates in the presence of excipients.
    Salameh AK; Taylor LS
    J Pharm Sci; 2006 Feb; 95(2):446-61. PubMed ID: 16380975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyphenated spectroscopy as a polymorph screening tool.
    Aaltonen J; Strachan CJ; Pöllänen K; Yliruusi J; Rantanen J
    J Pharm Biomed Anal; 2007 Jun; 44(2):477-83. PubMed ID: 17367979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-solvent co-crystallization of carbamazepine and saccharin.
    Wang IC; Lee MJ; Sim SJ; Kim WS; Chun NH; Choi GJ
    Int J Pharm; 2013 Jun; 450(1-2):311-22. PubMed ID: 23598078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.